Latest papers

Application of the iodine-azide postcolumn reaction in RP-HPLC for the determination of thioguanine in urine.

Azathioprine treatment photosensitizes human skin to ultraviolet A radiation.

Studies of thioguanine-resistant lymphocytes induced by in vivo irradiation of mice.

Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus.

Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes.

Risk factors for post-treatment hypogonadism in testicular cancer patients.

Variceal hemorrhage in a patient with ulcerative colitis treated with 6-Thioguanine.

Mammalian target of rapamycin and S6 kinase 1 positively regulate 6-thioguanine-induced autophagy.

Determination of leukocyte DNA 6-thioguanine nucleotide levels by high-performance liquid chromatography with fluorescence detection.

Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysis.

Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.

Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.

Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer.

Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.

[Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].

Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.

A case of acute loss of vision as the presenting symptom of Crohn's disease.

Early acute myeloblastic leukemia treatment for childhood myelodysplastic syndrome with t(3;5) (NPM/MLF1).

6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.

Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice.